Molecular monitoring of minimal residual disease in childhood acute lymphoblastic leukaemia using antigen receptor gene rearrangements is highly feasible for disease stratification and prognostication.
D002648:Child; D015321:Gene Rearrangement; D006801:Humans; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction / Q000379:methods; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000235:genetics*; D011379:Prognosis; D018570:Risk Assessment